Literature DB >> 2541552

Genetic analysis of CRPV pathogenesis: the L1 open reading frame is dispensable for cellular transformation but is required for papilloma formation.

M Nasseri1, C Meyers, F O Wettstein.   

Abstract

Genetic studies to elucidate the role of papillomaviruses in the development and progression of tumors have been severely hampered because the viruses cannot be grown in tissue culture and therefore mutants are not available. We have employed recombinant DNA for papilloma induction to identify essential sequences involved in papillomavirus pathogenesis. Here, we demonstrated that deleting most of the open reading frame (ORF) L2 did not affect the potential of viral cottontail rabbit papillomavirus (CRPV) DNA to induce papillomas. The extrachromosomally maintained DNA in the papillomas was not rearranged and the major transcripts of 1.3 and 2.0 kb encoded E7 and E6, respectively. A recombinant DNA containing a larger deletion lacking the 3' terminal half of ORF L2 and all of ORF L1 (pdlBc/l) did not induce papillomas. The results indicate that sequences in the late region not required for transformation of NIH 3T3 cells by bovine papillomavirus type-1 essential in CRPV for induction of papillomas.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2541552     DOI: 10.1016/0042-6822(89)90388-7

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  19 in total

1.  Cottontail Rabbit Papillomavirus E1 and E2 Proteins Mutually Influence Their Subcellular Localizations.

Authors:  Markus Schneider; Aylin Yigitliler; Frank Stubenrauch; Thomas Iftner
Journal:  J Virol       Date:  2018-10-12       Impact factor: 5.103

2.  Orf Virus-Based Therapeutic Vaccine for Treatment of Papillomavirus-Induced Tumors.

Authors:  M Schneider; M Müller; A Yigitliler; J Xi; C Simon; T Feger; H-J Rziha; F Stubenrauch; H-G Rammensee; T Iftner; R Amann
Journal:  J Virol       Date:  2020-07-16       Impact factor: 5.103

3.  A transactivator function of cottontail rabbit papillomavirus e2 is essential for tumor induction in rabbits.

Authors:  Sonja Jeckel; Evamaria Huber; Frank Stubenrauch; Thomas Iftner
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

4.  Vaccine generated immunity targets an HPV16 E7 HLA-A2.1-restricted CD8(+) T cell epitope relocated to an early gene or a late gene of the cottontail rabbit papillomavirus (CRPV) genome in HLA-A2.1 transgenic rabbits.

Authors:  Callie E Bounds; Jiafen Hu; Nancy M Cladel; Karla Balogh; Neil D Christensen
Journal:  Vaccine       Date:  2010-12-16       Impact factor: 3.641

5.  Changes in RNA expression pattern during the malignant progression of cottontail rabbit papillomavirus-induced tumors in rabbits.

Authors:  R Zeltner; L A Borenstein; F O Wettstein; T Iftner
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

6.  Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles.

Authors:  R Kirnbauer; J Taub; H Greenstone; R Roden; M Dürst; L Gissmann; D R Lowy; J T Schiller
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

7.  Identification of the E9/E2C cDNA and functional characterization of the gene product reveal a new repressor of transcription and replication in cottontail rabbit papillomavirus.

Authors:  Sonja Jeckel; Ekaterina Loetzsch; Evamaria Huber; Frank Stubenrauch; Thomas Iftner
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

8.  Papilloma formation by cottontail rabbit papillomavirus requires E1 and E2 regulatory genes in addition to E6 and E7 transforming genes.

Authors:  X Wu; W Xiao; J L Brandsma
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

9.  The putative E5 open reading frame of cottontail rabbit papillomavirus is dispensable for papilloma formation in domestic rabbits.

Authors:  J L Brandsma; Z H Yang; D DiMaio; S W Barthold; E Johnson; W Xiao
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

10.  Papillomavirus DNA complementation in vivo.

Authors:  Jiafen Hu; Nancy M Cladel; Lynn Budgeon; Karla K Balogh; Neil D Christensen
Journal:  Virus Res       Date:  2009-04-18       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.